Treatment of anal intraepithelial neoplasia in HIV-positive patients, a triple-arm randomized clinical trial

Trial Profile

Treatment of anal intraepithelial neoplasia in HIV-positive patients, a triple-arm randomized clinical trial

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Mar 2013

At a glance

  • Drugs Fluorouracil (Primary) ; Imiquimod (Primary)
  • Indications Anal cancer; Anal intraepithelial neoplasia
  • Focus Therapeutic Use
  • Acronyms TRAIN
  • Most Recent Events

    • 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
    • 16 Apr 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top